Paper23907438
Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form.
Qian WJ and 1 other. Amino Acids, 2013. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form. Papers, record 23907438. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23907438
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminobutyrates | Major topic |
| Peptides | Major topic |
| Phosphothreonine | Major topic |
| Prodrugs | Major topic |
| Molecular Structure | |
| Solid-Phase Synthesis Techniques |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Y99 CA999999 | NCI NIH HHS | United States | Y99CA999999 | PubMed | NIH RePORTER |
| Z99 CA999999 | Intramural NIH HHS | United States | Z99CA999999 | PubMed | NIH RePORTER |
| ZIA BC006198 | Intramural NIH HHS | United States | ZIABC006198 | PubMed and NIH | NIH RePORTER |
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22726690 | Synthesis of a phosphoserine mimetic prodrug with potent 14-3-3 protein inhibitory activity. | Chem Biol | 2012 | https://conductscience.org/library/papers/22726690 | PubMed |
| 2 | 19594124 | Synthesis of phosphatase-stable, cell-permeable peptidomimetic prodrugs that target the SH2 domain of Stat3. | Org Lett | 2009 | https://conductscience.org/library/papers/19594124 | PubMed |
| 3 | 17249650 | Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug. | J Med Chem | 2007 | https://conductscience.org/library/papers/17249650 | PubMed |
| 4 | 18359294 | Polo-box domains confer target specificity to the Polo-like kinase family. | Biochim Biophys Acta | 2008 | https://conductscience.org/library/papers/18359294 | PubMed |
| 5 | 21486047 | Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3. | J Med Chem | 2011 | https://conductscience.org/library/papers/21486047 | PubMed |
| 6 | 11667395 | Ready Access to Fluorinated Phosphonate Mimics of Secondary Phosphates. Synthesis of the (alpha,alpha-Difluoroalkyl)phosphonate Analogues of L-Phosphoserine, L-Phosphoallothreonine, and L-Phosphothreonine. | J Org Chem | 1996 | https://conductscience.org/library/papers/11667395 | PubMed |
| 7 | 11994738 | Phosphotyrosine-binding domains in signal transduction. | Nat Rev Mol Cell Biol | 2002 | https://conductscience.org/library/papers/11994738 | PubMed |
| 8 | 21284386 | Synthesis and biological evaluation of orally active prodrugs of indomethacin. | J Med Chem | 2011 | https://conductscience.org/library/papers/21284386 | PubMed |
| 9 | 7822106 | Efficient Fmoc/solid-phase synthesis of Abu(P)-containing peptides using Fmoc-Abu(PO3Me2)-OH. | Int J Pept Protein Res | 1994 | https://conductscience.org/library/papers/7822106 | PubMed |
| 10 | 21765407 | Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel. | Nat Chem Biol | 2011 | https://conductscience.org/library/papers/21765407 | PubMed |
| 11 | 22292814 | Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversification. | ACS Chem Biol | 2012 | https://conductscience.org/library/papers/22292814 | PubMed |
| 12 | 18237108 | Prodrugs of phosphates and phosphonates. | J Med Chem | 2008 | https://conductscience.org/library/papers/18237108 | PubMed |
| 13 | 10956468 | Stereoselective synthesis of CF(2)-substituted phosphothreonine mimetics and their incorporation into peptides using newly developed deprotection procedures. | J Org Chem | 2000 | https://conductscience.org/library/papers/10956468 | PubMed |
| 14 | 12809529 | Phosphotyrosyl mimetics in the development of signal transduction inhibitors. | Acc Chem Res | 2003 | https://conductscience.org/library/papers/12809529 | PubMed |
| 15 | 12614874 | Prodrugs of biologically active phosphate esters. | Bioorg Med Chem | 2003 | https://conductscience.org/library/papers/12614874 | PubMed |
| 16 | 22161995 | Current chemical biology tools for studying protein phosphorylation and dephosphorylation. | Chemistry | 2012 | https://conductscience.org/library/papers/22161995 | PubMed |
| 17 | 22570300 | Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1. | Chembiochem | 2012 | https://conductscience.org/library/papers/22570300 | PubMed |
| 18 | 24954959 | Preparation of orthogonally protected (2S, 3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of Polo-box domain-binding peptides. | Tetrahedron | 2009 | https://conductscience.org/library/papers/24954959 | PubMed |
| 19 | 19778720 | The alpha,alpha-difluorinated phosphonate L-pSer-analogue: an accessible chemical tool for studying kinase-dependent signal transduction. | Chem Biol | 2009 | https://conductscience.org/library/papers/19778720 | PubMed |
| 20 | 17935986 | A phosphorylated prodrug for the inhibition of Pin1. | Bioorg Med Chem Lett | 2007 | https://conductscience.org/library/papers/17935986 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35518575 | Phosphonopeptides containing free phosphonic groups: recent advances. | RSC Adv | 2020 | https://conductscience.org/library/papers/35518575 | PubMed |
| 30174151 | Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors. | Bioorg Med Chem Lett | 2018 | https://conductscience.org/library/papers/30174151 | PubMed |
| 25391982 | Prodrugs of phosphonates and phosphates: crossing the membrane barrier. | Top Curr Chem | 2015 | https://conductscience.org/library/papers/25391982 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23907438
GET https://conductscience.org/api/papers/v1/23907438/references?page=2